These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26812442)

  • 21. Changes in event-related potentials with stimulant medication in children with attention deficit hyperactivity disorder.
    Taylor MJ; Voros JG; Logan WJ; Malone MA
    Biol Psychol; 1993 Sep; 36(3):139-56. PubMed ID: 8260563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate.
    Sangal RB; Sangal JM
    Clin Neurophysiol; 2004 Jan; 115(1):188-93. PubMed ID: 14706487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Investigation of Stimulant Effects on the EEG of Children With Attention-Deficit/Hyperactivity Disorder.
    Clarke AR; Barry RJ; Baker IE; McCarthy R; Selikowitz M
    Clin EEG Neurosci; 2017 Jul; 48(4):235-242. PubMed ID: 27552823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Modulation of Neural Noise Underlies the Effectiveness of Methylphenidate Treatment in Attention-Deficit/Hyperactivity Disorder.
    Pertermann M; Bluschke A; Roessner V; Beste C
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Aug; 4(8):743-750. PubMed ID: 31103546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of Heart Rate Variability during Methylphenidate Treatment in Attention-Deficit Hyperactivity Disorder Children: A 12-Week Prospective Study.
    Kim HJ; Yang J; Lee MS
    Yonsei Med J; 2015 Sep; 56(5):1365-71. PubMed ID: 26256981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantitative effect of treatment with methylphenidate on EEG--a pilot study].
    Kerdar MS; Scheuerpflug P; Srdinko P; Wewetzer C; Warnke A; Romanos M
    Z Kinder Jugendpsychiatr Psychother; 2007 Jul; 35(4):247-55; quiz 255-6. PubMed ID: 17970368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
    Brackenridge R; McKenzie K; Murray GC; Quigley A
    Res Dev Disabil; 2011; 32(6):2797-804. PubMed ID: 21700419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurofeedback for the treatment of attention-deficit/hyperactivity disorder (ADHD) in childhood and adolescence].
    Holtmann M; Stadler C; Leins U; Strehl U; Birbaumer N; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2004 Jul; 32(3):187-200. PubMed ID: 15357015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder.
    Smithee JA; Klorman R; Brumaghim JT; Borgstedt AD
    J Abnorm Child Psychol; 1998 Aug; 26(4):233-45. PubMed ID: 9700516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of osmotic-release methylphenidate in attention-deficit/hyperactivity disorder as measured by event-related potentials.
    Sawada M; Iida J; Ota T; Negoro H; Tanaka S; Sadamatsu M; Kishimoto T
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):491-8. PubMed ID: 20923428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder.
    Hong SB; Harrison BJ; Fornito A; Sohn CH; Song IC; Kim JW
    J Psychiatry Neurosci; 2015 Jan; 40(1):46-57. PubMed ID: 25266402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder.
    Malone MA; Kershner JR; Swanson JM
    J Child Neurol; 1994 Apr; 9(2):181-9. PubMed ID: 8006372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of the electroencephalogram in attention deficit hyperactivity disorder.
    Millichap JG; Millichap JJ; Stack CV
    Clin EEG Neurosci; 2011 Jul; 42(3):180-4. PubMed ID: 21870470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EEG correlates of methylphenidate response among children with ADHD: a preliminary report.
    Loo SK; Teale PD; Reite ML
    Biol Psychiatry; 1999 Jun; 45(12):1657-60. PubMed ID: 10376129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with methylphenidate.
    Fuchs T; Birbaumer N; Lutzenberger W; Gruzelier JH; Kaiser J
    Appl Psychophysiol Biofeedback; 2003 Mar; 28(1):1-12. PubMed ID: 12737092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.